Back
Day Range
$153.46
$159.40
52-Week Range
$86.99
$191.50
Volume
378,201
50D / 200D Avg
$174.32
/
$137.24
Prev Close
$156.92
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -43.8 | 0.4 |
| P/B | 90.9 | 2.9 |
| ROE % | -252.1 | 3.8 |
| Net Margin % | -28.7 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 2.7 | 0.2 |
Key Takeaways
Debt/Equity of 2.73 — high leverage
Negative free cash flow of -93.41M
Capital efficient — spends only 0.00% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)65.55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-252.11%
ROIC-38.51%
Net Margin-28.69%
Op. Margin-26.51%
Safety
Debt / Equity
2.73
Current Ratio1.55
Interest Coverage-25.81
Valuation
P/E Ratio
-43.80
P/B Ratio90.86
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 65.55% | Revenue Growth (3Y) | 53.61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 638.50M | Net Income (TTM) | -183.17M |
| ROE | -252.11% | ROA | -26.55% |
| Gross Margin | 92.56% | Operating Margin | -26.51% |
| Net Margin | -28.69% | Free Cash Flow (TTM) | -93.41M |
| ROIC | -38.51% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.73 | Current Ratio | 1.55 |
| Interest Coverage | -25.81 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -43.80 | P/B Ratio | 90.86 |
| P/S Ratio | 12.57 | PEG Ratio | 1.29 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 8.02B | Enterprise Value | 7.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 638.50M | 385.69M | 270.60M | 50.04M | 0.0 |
| Net Income | -183.17M | -287.22M | -239.24M | -187.13M | -130.40M |
| EPS (Diluted) | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
| Gross Profit | 591.02M | 352.39M | 244.54M | 44.84M | 0.0 |
| Operating Income | -169.24M | -280.56M | -231.83M | -179.80M | -124.71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 689.81M | 568.50M | 588.24M | 331.48M | 87.79M |
| Total Liabilities | 601.51M | 511.48M | 397.26M | 221.92M | 72.15M |
| Shareholders' Equity | 88.30M | 57.02M | 190.98M | 109.56M | 15.63M |
| Total Debt | 241.30M | 192.96M | 186.37M | 94.68M | 49.71M |
| Cash & Equivalents | 322.93M | 315.35M | 386.19M | 200.84M | 86.47M |
| Current Assets | 588.99M | 485.06M | 504.26M | 245.64M | 86.52M |
| Current Liabilities | 378.84M | 230.10M | 138.85M | 96.56M | 23.07M |